Edition:
India

Insider Trading: Crinetics Pharmaceuticals Inc (CRNX.OQ)

CRNX.OQ on NASDAQ Stock Exchange Global Select Market

16.09USD
21 Oct 2019
Change (% chg)

-- (--)
Prev Close
$16.09
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
24,582
52-wk High
$36.28
52-wk Low
$14.46

All Insider Trades
Trading Date Name Title Type Shares Traded Price
21 Jun 2019

5AM Ventures IV, L.P.

Unknown Sell 10,000 $22.20
21 Jun 2019

5AM Ventures IV, L.P.

Unknown Sell 240,000 $22.20
20 Mar 2019

Vivo Capital VIII, L.L.C.

Beneficial Owner of More than 10% Class Sell 292,609 $22.25
20 Mar 2019

Vivo Capital VIII, L.L.C.

Beneficial Owner of More than 10% Class Sell 40,407 $22.25
20 Mar 2019

Vivo Capital VIII, L.L.C.

Beneficial Owner of More than 10% Class Sell 83,984 $22.25
18 Mar 2019

5AM Ventures IV, L.P.

Beneficial Owner of More than 10% Class Sell 6,194 $24.25
18 Mar 2019

5AM Ventures IV, L.P.

Beneficial Owner of More than 10% Class Sell 148,645 $24.25
20 Feb 2019

5AM Ventures IV, L.P.

Beneficial Owner of More than 10% Class Buy 783 $0.00
20 Feb 2019

5AM Ventures IV, L.P.

Beneficial Owner of More than 10% Class Sell 4,700 $0.00
20 Feb 2019

5AM Ventures IV, L.P.

Beneficial Owner of More than 10% Class Sell 451,200 $0.00
20 Feb 2019

5AM Ventures IV, L.P.

Beneficial Owner of More than 10% Class Buy 940 $0.00
20 Feb 2019

5AM Ventures IV, L.P.

Beneficial Owner of More than 10% Class Buy 783 $0.00
20 Feb 2019

5AM Ventures IV, L.P.

Beneficial Owner of More than 10% Class Buy 587 $0.00
20 Feb 2019

5AM Ventures IV, L.P.

Beneficial Owner of More than 10% Class Buy 940 $0.00
20 Feb 2019

5AM Ventures IV, L.P.

Beneficial Owner of More than 10% Class Sell 18,800 $0.00
20 Feb 2019

5AM Ventures IV, L.P.

Beneficial Owner of More than 10% Class Buy 4,700 $0.00
20 Feb 2019

5AM Ventures IV, L.P.

Beneficial Owner of More than 10% Class Buy 783 $0.00
20 Feb 2019

5AM Ventures IV, L.P.

Beneficial Owner of More than 10% Class Buy 353 $0.00
22 Jan 2019

5AM Ventures IV, L.P.

Beneficial Owner of More than 10% Class Sell 251,667 $21.88
22 Jan 2019

5AM Ventures IV, L.P.

Beneficial Owner of More than 10% Class Sell 10,486 $21.88
20 Nov 2018

Krasner (Alan Seth)

Officer Buy 1,470 $14.45
20 Nov 2018

Wilson (Marc)

Chief Financial Officer Buy 1,470 $14.45
20 Jul 2018

5AM Ventures IV, L.P.

Beneficial Owner of More than 10% Class Buy 110,400 $17.00
20 Jul 2018

Vivo Capital VIII, L.L.C.

Beneficial Owner of More than 10% Class Buy 413,040 $0.00
20 Jul 2018

Vivo Capital VIII, L.L.C.

Beneficial Owner of More than 10% Class Buy 153,180 $20.73

Institutional Holders

% Shares Owned: 97.63%
# of Holders: 101
Total Shares Held: 23,565,554
3 Mo. Net Change: -1,345,839
# New Positions: 5
# Closed Positions: 1
# Increased Positions: 10
# Reduced Positions: 5
# Net Buyers: 5

Officers & Directors

Name Age Since Current Position

Wendall Wierenga

70 2015 Independent Chairman of the Board

R. Scott Struthers

56 2008 President, Chief Executive Officer, Director

Marc Wilson

39 2018 Chief Financial Officer

Stephen Betz

52 2009 Vice President - Biology

Gina Ford

2019 Vice President, Corporate Strategy and Commercial Planning

Ajay Madan

50 2016 Vice President - Development

Yun-Fei Zhu

55 2009 Vice President - Chemistry

Alan Krasner

54 2018 Chief Medical Officer

Mason Freeman

67 2015 Independent Director

Matthew Fust

54 2018 Independent Director

Stephen Kaldor

56 2015 Independent Director

Weston Nichols

33 2018 Independent Director

Jack Nielsen

55 2018 Independent Director

Stephanie Okey

59 2019 Independent Director